CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement.

Shumilov, Evgenii; Boyadzhiev, Hristo; Mazzeo, Paolo; Akhoundova, Dilara; Daskalakis, Michael; Novak, Urban; Lenz, Georg; Bacher, Ulrike; Pabst, Thomas (2023). CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement. HemaSphere, 7(12), e984. Wolters Kluwer Health 10.1097/HS9.0000000000000984

[img]
Preview
Text
car_t_cell_therapy_shows_similar_efficacy_and.7.pdf - Published Version
Available under License Creative Commons: Attribution-Share Alike (CC-BY-SA).

Download (2MB) | Preview

Efficacy and toxicity of chimeric antigen receptor T (CAR-T) cell therapy in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) involvement remain understudied. Here we analyzed the outcomes of CAR-T cell therapy in r/r DLBCL patients with CNS involvement and compared them with patients without CNS disease. Retrospective and monocentric comparative analysis of patient cohort with r/r DLBCL treated with CAR-T cell therapy: 15 patients with CNS versus 65 patients without CNS involvement. Overall response rates (80% versus 80%; P = 1.0), progression-free survival (P = 0.157), and overall survival (P = 0.393) were comparable for both cohorts. The frequency of cytokine release syndrome was comparable in the CNS and non-CNS cohorts; 93% versus 80%; P = 1.0. Numerically, immune effector-cell-associated neurotoxicity syndrome (all grades) was more frequent in patients with CNS manifestation (53% versus 29%; P = 0.063), although no grade 4 events were documented. Our study suggests that CAR-T cell therapy is effective and feasible in patients with r/r DLBCL and CNS manifestation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Akhoundova Sanoyan, Dilara, Daskalakis, Michael, Novak, Urban, Bacher, Vera Ulrike, Pabst, Thomas Niklaus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2572-9241

Publisher:

Wolters Kluwer Health

Language:

English

Submitter:

Pubmed Import

Date Deposited:

06 Dec 2023 10:51

Last Modified:

10 Dec 2023 02:30

Publisher DOI:

10.1097/HS9.0000000000000984

PubMed ID:

38044958

BORIS DOI:

10.48350/189819

URI:

https://boris.unibe.ch/id/eprint/189819

Actions (login required)

Edit item Edit item
Provide Feedback